In 20–25% of invasive breast cancers, HER-2 gene is either overexpressed or amplified.4 As an epidermal growth factor receptor (EGFR), HER-2 is not known to bind with any known ligands but can heterodimerize with other related EGFR family members. Here, ERBB2 is linked to invasive breast carcinoma.